...
首页> 外文期刊>Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research >Cost-Effectiveness of the Introduction of a Pre-Erythrocytic Malaria Vaccine into the Expanded Program on Immunization in Sub-Saharan Africa: Analysis of Uncertainties Using a Stochastic Individual-Based Simulation Model of Plasmodium falciparum Malaria
【24h】

Cost-Effectiveness of the Introduction of a Pre-Erythrocytic Malaria Vaccine into the Expanded Program on Immunization in Sub-Saharan Africa: Analysis of Uncertainties Using a Stochastic Individual-Based Simulation Model of Plasmodium falciparum Malaria

机译:成本效益的介绍Pre-Erythrocytic疟疾疫苗的扩大免疫规划在撒哈拉以南非洲:不确定性分析使用随机的基于单独的仿真模型恶性疟原虫疟疾

获取原文
获取原文并翻译 | 示例

摘要

Objective: To evaluate the cost-effectiveness of introducing the RTS.S malaria vaccine into the Expanded Programme on Immunization (EPI) in Sub-Saharan Africa (SSA), the contributions of different sources of uncertainty, and the associated expected value of perfect information (EVPI). Methods: Vaccination was simulated in populations of 100,000 people at 10 different entomological inoculation rates (EIRs), using an existing stochastic model and a 10-year time horizon. Incremental cost-effectiveness ratios (ICERs) and EVPI were computed from weighted averages of outputs using two different assignments of the EIR distribution in 2007. Uncertainty was evaluated by resampling of epidemiological, vaccination, and health systems model parameters. Results: Health benefits were predicted consistently only at low transmission, and program costs always substantially exceeded case management savings. Optimal cost-effectiveness was at EIR of about 10 infectious bites per annum (ibpa). Main contributors to ICER uncertainty were uncertainty in transmission intensity, price per vaccinedose, decay rate of the vaccine effect, degree of homogeneity in host response, and some epidemiological model parameters. Other health system costs were unimportant. With a ceiling ratio of 207 international dollars per disability-adjusted life-year averted, 52.4% of param-eterizations predicted cost-effectiveness in the primary analysis. Conclusions: Cost-effectiveness of RTS.S will be maximal in low ende-micity settings (EIR 2-20 ibpa). Widespread deployment of other transmission-reducing interventions will thus improve cost-effectiveness, suggesting a selective introduction strategy. EVPI is substantial. Accrual of up-to-date information on local endemicity to guide deployment decisions would be highly efficient.
机译:目的:评估的成本效益引入RTS。扩大免疫规划(EPI)撒哈拉以南非洲地区(SSA)的贡献不同来源的不确定性,完全信息的期望值有关(EVPI)。在10个不同的人口100000人昆虫学接种率(常驻企业家们),使用一个现有的随机模型和10年时间地平线。(警察)和EVPI是从加权计算的平均使用两种不同的输出2007年作业EIR分布。不确定性评价的重采样流行病学、预防接种和卫生系统模型参数。预测一直只在低传输,和项目成本总是大大超过病例管理储蓄。成本效益在EIR约10每年传染性咬(ibpa)。贡献者冷藏工人不确定性是不确定性在传播强度,每vaccinedose价格,衰变率的疫苗效果,度同质性在宿主的反应,和一些流行病学模型参数。系统成本是不重要的。207年国际美元的比例残疾调整生命年避免,52.4%的param-eterizations预测成本效益在主要的分析。RTS的成本效益。广泛部署的其他transmission-reducing干预措施将提高成本效益,暗示选择性引进策略。可观。当地的风土性指导部署决策将高效。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号